NDC codes

415010 NDC codes with hospital pricing data in the network.

• NDC 00067-8152-03 — Voltaren arthritis pain gel 1%AI (388 hospitals, 42,045–43,206 samples)
• NDC 65862-0390-10 — Ondansetron 4 mg dissolving tabletAI (703 hospitals, 36,000–43,173 samples)
• NDC 00143-9262-25 — Cefazolin sodium injection, 500 mgAI (318 hospitals, 36,322–43,126 samples)
• NDC 63323-0563-01 — Tranexamic acid 1,000 mg/10 mL intravenous solutionAI (86 hospitals, 42,246–43,074 samples)
• NDC 64980-0320-05 — Triamcinolone topical paste, 5 gram tubeAI (517 hospitals, 41,946–43,008 samples)
• NDC 00409-1005-20 — Heparin in saline IV solutionAI (217 hospitals, 41,216–42,737 samples)
• NDC 00046-0872-21 — Premarin 0.625 mg/g vaginal creamAI (878 hospitals, 41,169–42,699 samples)
• NDC 00409-7983-61 — Sodium chloride 0.9% IV solutionAI (149 hospitals, 40,020–42,657 samples)
• NDC 55150-0170-30 — Bupivacaine 0.5% injection, preservative-freeAI (875 hospitals, 32,267–42,644 samples)
• NDC 69315-0306-15 — Nystatin 100,000 unit/gram topical powderAI (547 hospitals, 41,248–42,634 samples)
• NDC 67457-0421-30 — Dexamethasone sodium phosphate 120 mg injectionAI (303 hospitals, 38,547–42,534 samples)
• NDC 52565-0008-14 — LIDOCAINE 5 % TOPICAL OINTMENTAI (262 hospitals, 41,426–42,533 samples)
• NDC 00264-7612-00 — Dextrose and saline IV solutionAI (352 hospitals, 41,788–42,481 samples)
• NDC 43598-0265-25 — Propofol injection 10 mg/mL, 20 mLAI (107 hospitals, 42,064–42,460 samples)
• NDC 72611-0719-01 — Ketorolac 15 mg/mL injectionAI (213 hospitals, 40,129–42,415 samples)
• NDC 45802-0112-22 — Mupirocin 2% topical ointmentAI (873 hospitals, 40,978–42,382 samples)
• NDC 70860-0301-43 — Diltiazem injection, 25 mL vialAI (347 hospitals, 40,260–42,357 samples)
• NDC 67457-0441-20 — Ondansetron injection (intravenous anti-nausea medicine)AI (123 hospitals, 40,546–42,328 samples)
• NDC 70069-0064-01 — Ropivacaine hydrochloride injection, 5 mg/mLAI (527 hospitals, 40,973–42,260 samples)
• NDC 70092-1093-37 — Fentanyl pain medicine in saline IVAI (275 hospitals, 40,403–42,221 samples)
• NDC 17238-0424-06 — Indocyanine green injection, 25 mg vialAI (211 hospitals, 41,509–42,193 samples)
• NDC 00270-1316-01 — Low-osmolar iodinated contrast dye, per milliliterAI (47 hospitals, 42,034–42,178 samples)
• NDC 00168-0007-15 — Nystatin 100,000 unit topical ointmentAI (269 hospitals, 41,071–42,142 samples)
• NDC 00713-0683-15 — Gentamicin 0.1% topical creamAI (512 hospitals, 41,077–42,121 samples)
• NDC 00409-6729-24 — Magnesium sulfate IV solution 2 g in 50 mLAI (683 hospitals, 38,508–42,081 samples)
• NDC 25021-0687-05 — Rocuronium injection, 10 mg/mL intravenous solutionAI (192 hospitals, 40,958–42,002 samples)
• NDC 00407-2223-23 — Iodixanol 320 mg/mL intravenous contrastAI (100 hospitals, 37,454–41,918 samples)
• NDC 68516-5216-01 — Albumin 25% intravenous solutionAI (647 hospitals, 39,595–41,908 samples)
• NDC 49884-0161-11 — Calcitonin (salmon) nasal spray, 200 units per sprayAI (706 hospitals, 40,679–41,858 samples)
• NDC 61314-0227-05 — Timolol eye drops 0.5%AI (1100 hospitals, 40,503–41,754 samples)
• NDC 63323-0162-26 — Ketorolac tromethamine 60 mg/2 mL intramuscular injectionAI (239 hospitals, 40,035–41,745 samples)
• NDC 00409-1160-18 — Bupivacaine 0.25% injection solutionAI (277 hospitals, 38,462–41,738 samples)
• NDC 17478-0070-31 — Erythromycin eye ointmentAI (334 hospitals, 39,747–41,700 samples)
• NDC 61314-0019-10 — Dorzolamide 2% eye dropsAI (813 hospitals, 40,496–41,693 samples)
• NDC 00641-6029-01 — Fentanyl citrate injection, preservative-free, 1000 mcg per 20 mL vialAI (253 hospitals, 36,199–41,626 samples)
• NDC 63323-0374-20 — Ondansetron injection (IV solution)AI (188 hospitals, 39,054–41,619 samples)
• NDC 00168-0146-30 — hydrocortisone 2.5 % topical ointmentAI (491 hospitals, 40,516–41,605 samples)
• NDC 57894-0503-01 — Daratumumab subcutaneous injection (Darzalex Faspro)AI (1075 hospitals, 39,509–41,579 samples)
• NDC 68462-0418-20 — Lidocaine 5% ointmentAI (430 hospitals, 40,126–41,575 samples)
• NDC 00338-9151-30 — Sodium chloride 0.9% IV solutionAI (179 hospitals, 41,141–41,555 samples)
• NDC 63323-0162-45 — Ketorolac 60 mg/2 mL injection for muscleAI (124 hospitals, 39,144–41,538 samples)
• NDC 71858-0110-05 — Levothyroxine liquid, 25 mcg per mL oral solutionAI (55 hospitals, 41,115–41,520 samples)
• NDC 00641-6194-01 — Propofol injection 10 mg/mL, 20 mL vialAI (90 hospitals, 41,253–41,514 samples)
• NDC 51672-1312-00 — Mupirocin 2% ointmentAI (801 hospitals, 40,268–41,501 samples)
• NDC 00338-1709-40 — Magnesium sulfate in dextrose IV solutionAI (696 hospitals, 37,457–41,498 samples)
• NDC 72611-0725-25 — Ketorolac 60 mg injectionAI (207 hospitals, 39,729–41,457 samples)
• NDC 63323-0496-97 — Lidocaine injection, preservative-free, 2%AI (499 hospitals, 36,681–41,406 samples)
• NDC 61314-0547-01 — Latanoprost eye drops 0.005%AI (1005 hospitals, 40,053–41,331 samples)
• NDC 00409-2308-01 — Midazolam injection, 5 mg/mLAI (672 hospitals, 37,382–41,324 samples)
• NDC 00378-9104-93 — Nitroglycerin 24-hour skin patch, 0.2 mg per hourAI (711 hospitals, 39,996–41,238 samples)